Showing 1 to 12 of 70 results
UK Medicine Prices Must Rise to Attract Pharmaceutical Investment, Says Science Minister
Science minister Patrick Vallance says the UK must raise NHS medicine prices to prevent pharmaceutical companies from pulling investment from the country, following recent project cancellations by major drugmakers.
UK Medicine Prices Must Rise to Attract Pharmaceutical Investment, Says Science Minister
Science minister Patrick Vallance says the UK must raise NHS medicine prices to prevent pharmaceutical companies from pulling investment from the country, following recent project cancellations by major drugmakers.
Progress
48% Bias Score
Trump's Misleading Claim of 1000% Prescription Drug Price Reduction
President Trump repeatedly claims his "most favored nation" policy will cut prescription drug prices by 1000% or more, a mathematically impossible assertion; this claim is factually inaccurate, as a 100% reduction would mean the price drops to zero.
Trump's Misleading Claim of 1000% Prescription Drug Price Reduction
President Trump repeatedly claims his "most favored nation" policy will cut prescription drug prices by 1000% or more, a mathematically impossible assertion; this claim is factually inaccurate, as a 100% reduction would mean the price drops to zero.
Progress
44% Bias Score
Trump to Drugmakers: Raise Prices Abroad to Lower US Costs
President Trump plans to pressure drug manufacturers to increase prices in other countries to offset price reductions in the US, potentially impacting global drug pricing and raising legal concerns.
Trump to Drugmakers: Raise Prices Abroad to Lower US Costs
President Trump plans to pressure drug manufacturers to increase prices in other countries to offset price reductions in the US, potentially impacting global drug pricing and raising legal concerns.
Progress
24% Bias Score
UK Drug Pricing Dispute: NHS Faces Industry Backlash Over Clawback Scheme
The UK government and pharmaceutical companies failed to agree on NHS drug pricing by a Friday deadline, resulting in the continuation of a drug price clawback scheme at a rate the industry deems unsustainable, potentially affecting patient access to new medicines and the UK's life sciences sector.
UK Drug Pricing Dispute: NHS Faces Industry Backlash Over Clawback Scheme
The UK government and pharmaceutical companies failed to agree on NHS drug pricing by a Friday deadline, resulting in the continuation of a drug price clawback scheme at a rate the industry deems unsustainable, potentially affecting patient access to new medicines and the UK's life sciences sector.
Progress
56% Bias Score
Novo Nordisk Halves Ozempic Price for Uninsured Americans
Novo Nordisk slashed Ozempic's price by over 50% to $499/month for three doses for uninsured Americans, available via its website and GoodRx, following political pressure and shortages of the semaglutide active ingredient.
Novo Nordisk Halves Ozempic Price for Uninsured Americans
Novo Nordisk slashed Ozempic's price by over 50% to $499/month for three doses for uninsured Americans, available via its website and GoodRx, following political pressure and shortages of the semaglutide active ingredient.
Progress
36% Bias Score
Novo Nordisk's Share Price Plummets Amidst Increased Competition and Market Challenges
Novo Nordisk's share price plummeted over 50 percent this year due to increased competition from Eli Lilly's Mounjaro, the prevalence of cheaper compounded GLP-1 drugs, and slower adaptation to market changes, leading to a significant loss in market value and a CEO change.
Novo Nordisk's Share Price Plummets Amidst Increased Competition and Market Challenges
Novo Nordisk's share price plummeted over 50 percent this year due to increased competition from Eli Lilly's Mounjaro, the prevalence of cheaper compounded GLP-1 drugs, and slower adaptation to market changes, leading to a significant loss in market value and a CEO change.
Progress
56% Bias Score
EU Drug Shortages Reach Record Levels in 2023-2024
A European Court of Auditors report reveals that shortages of 136 essential medicines reached record levels in the EU in 2023 and 2024, impacting 21 member states and driven by factors like increased demand, production delays, and high energy costs.
EU Drug Shortages Reach Record Levels in 2023-2024
A European Court of Auditors report reveals that shortages of 136 essential medicines reached record levels in the EU in 2023 and 2024, impacting 21 member states and driven by factors like increased demand, production delays, and high energy costs.
Progress
16% Bias Score
German Health Minister Announces Expansion of Pharmacy Services
German Health Minister Nina Warken announced plans to expand pharmacy services, including vaccinations and preventative care, to alleviate pressure on doctor's offices, while delaying a planned increase in pharmacy reimbursement.
German Health Minister Announces Expansion of Pharmacy Services
German Health Minister Nina Warken announced plans to expand pharmacy services, including vaccinations and preventative care, to alleviate pressure on doctor's offices, while delaying a planned increase in pharmacy reimbursement.
Progress
32% Bias Score
Trump to Pressure Drugmakers to Raise Prices in Other Countries to Offset US Reductions
President Trump plans to pressure pharmaceutical companies to increase drug prices in other countries to compensate for price reductions in the US, potentially impacting global drug affordability and research investment.
Trump to Pressure Drugmakers to Raise Prices in Other Countries to Offset US Reductions
President Trump plans to pressure pharmaceutical companies to increase drug prices in other countries to compensate for price reductions in the US, potentially impacting global drug affordability and research investment.
Progress
28% Bias Score
Novo Nordisk Offers $499 Ozempic to US Patients
Novo Nordisk is offering a monthly supply of Ozempic for $499 to US patients who pay out-of-pocket, responding to President Trump's calls to lower drug costs and addressing sales impacts from compounding pharmacies.
Novo Nordisk Offers $499 Ozempic to US Patients
Novo Nordisk is offering a monthly supply of Ozempic for $499 to US patients who pay out-of-pocket, responding to President Trump's calls to lower drug costs and addressing sales impacts from compounding pharmacies.
Progress
40% Bias Score
Mounjaro UK Price Soars 170% Amid US Cost-Cutting Push
Eli Lilly announced a 170% price hike for its weight-loss drug Mounjaro in the UK, increasing the highest dose to £330 per month, to align UK pricing with other European markets and lower US costs, though the NHS remains unaffected.
Mounjaro UK Price Soars 170% Amid US Cost-Cutting Push
Eli Lilly announced a 170% price hike for its weight-loss drug Mounjaro in the UK, increasing the highest dose to £330 per month, to align UK pricing with other European markets and lower US costs, though the NHS remains unaffected.
Progress
52% Bias Score
Mounjaro Price Hike in UK Reaches 170% Amidst Trump's Drug Pricing Pressure
Eli Lilly will increase the price of its weight-loss injection Mounjaro in the UK by up to 170% from September, aligning it with other European markets despite the NHS not paying the increased price; this follows pressure from Donald Trump to lower US drug prices by reducing prices in Europe.
Mounjaro Price Hike in UK Reaches 170% Amidst Trump's Drug Pricing Pressure
Eli Lilly will increase the price of its weight-loss injection Mounjaro in the UK by up to 170% from September, aligning it with other European markets despite the NHS not paying the increased price; this follows pressure from Donald Trump to lower US drug prices by reducing prices in Europe.
Progress
48% Bias Score
Showing 1 to 12 of 70 results